Abstract
Mycoplasma pneumoniae, atypical bacterium known for causing respiratory infections, has risen as a major public health concern worldwide. This agent, primarily responsible for 'walking pneumonia', is infamous for triggering outbreaks in densely populated areas such as schools, hospitals, and military bases. Although typically mild, its global effect is profound, with around 2 million cases reported each year. The recent increase in cases in China closely mirrors the early indications of an unidentified pneumonia outbreak in Wuhan in late 2019, which signaled the beginning of the COVID-19 pandemic. Contributing factors to these developments may include influenza, respiratory syncytial virus, SARS-CoV-2, and influenza. This article sheds light on the public health challenges brought forth by Mycoplasma pneumoniae, emphasizing its notable spread in nations including Denmark, the Netherlands, South Korea, Singapore, the USA, and Sweden, thereby highlighting its extensive global reach.
Keywords:
mycoplasma pneumoniae, respiratory infections, undiagnosed pneumonia, walking pneumonia, atypical pneumonia, antibiotic resistance, disease surveillance, preventive measuresReferences
Hu J, Ye Y, Chen X, Xiong L, Xie W, Liu P. Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae. Current Microbiology. 2022;80(1):14.
Tang M, Wang D, Tong X, Wu Y, Zhang J, Zhang L, et al. Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia. BMC Pediatrics. 2021;21(1):90.
Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30(3):747-809.
Conroy G. What’s behind China’s mysterious wave of childhood pneumonia? Nature. 2023.
Schnirring L. Denmark reports Mycoplasma pneumonia epidemic. CIDRAP. 2023 30 November 2023.
Kiel BAJ. Mycoplasma Pneumonia. Treasure Island (FL): StatPearls Publishing; 2023.
Zhang X-S, Zhao H, Vynnycky E, Chalker V. Positively interacting strains that co-circulate within a network structured population induce cycling epidemics of Mycoplasma pneumoniae. Scientific Reports. 2019;9(1):541.
Upsurge of respiratory illnesses among children-Northern China. Disease Outbreak News. World Health Organization (WHO); 2023.
Mycoplasma pneumoniae Infections. CDC, Atlanta, USA, National Center for Immunization and Respiratory Diseases DoBD; 2023.
Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clinical Microbiology Reviews. 2017;30(3):747-809.
Kashyap S, Sarkar M. Mycoplasma pneumonia: Clinical features and management. Lung India. 2010;27(2):75-85.
Leng M, Yang J, Zhou J. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Frontiers in Pediatrics. 2023;11.
Jiang Z, Li S, Zhu C, Zhou R, Leung PHM. Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development. Pathogens. 2021;10(2).
Mun-Keat L. China: Rising cases of respiratory disease and pneumonia spark WHO concern. BMJ. 2023;383:p2770.
Looi MK. China: Rising cases of respiratory disease and pneumonia spark WHO concern. Bmj. 2023;383:2770.
Meyer Sauteur PM, Beeton ML. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2023.
How to Cite
License
Copyright (c) 2023 The Evidence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright© by the author(s). Published by the Evidence Journals. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Most read articles by the same author(s)
- Krati Agarwal, Shriyansh Srivastava, Vanya Singh, Ranjana Rohilla, Kamran Zaman, Atul Rukadikar, Parul Singh, Vivek Hada, Aroop Mohanty, Rama Shankar Rath, Surekha Kishore, Ranjit Sah, One health concept and its applications in clinical practice: a comprehensive review , The Evidence: Vol. 2 No. 1 (2024): JAN - MAR
- Muhammed Shabil, Ganesh Bushi, Aarti Yadav, Mohammed Ahmed, Jugal Kishore, Sarath Lekamwasam, Ashish Joshi, Effect of metformin on cardiovascular outcomes: a systematic review and meta-analysis of observational studies and RCTs , The Evidence: Vol. 1 No. 1 (2023): OCT - DEC
- Amaljith A B, Roy Rillera Marzo, Sarath Lekamwasam, Adnan Kisa, Ashish Behera, Preetha S, Praveen Bharath Saravanan, Pankaj B Shah, Subarna Sinha Mahapatra, Gopi Kumbha, Vishaal P, Swathika N. Rama , Noor ul Baddar, Denny Mathew John, Vineeth Rajagopal, Prevalence of fall and its associated factors among elderly population in India: Evidence from the Longitudinal Aging Study of India (LASI) , The Evidence: Vol. 2 No. 2 (2024): APR - JUN
- Meenu Singh, Joseph L. Mathew, Ranjit Sah, Celso Augusto Guimarães Santos, Adnan Kisa, Alfonso J. Rodríguez-Morales, Ashish Joshi, Jagdish Khubchandani, Jugal Kishore, Roy Rillera Marzo, Atin Adhikari, Abdulai Abubakari, Aditya Singh, Ahmad Neyazi, Aroop Mohanty, Russell Kabir, Vasso Apostolopoulos, Abhishek Mewara, Aravind P Gandhi, Bijaya K Padhi, Navigating the future of academic publishing: mission and vision of "The Evidence" , The Evidence: Vol. 1 No. 1 (2023): OCT - DEC
- Pawan Kumar, Vinay Suresh, Praveen Bharath Saravanan, Amit Kumar, Ayush Sharma, Battling bovine leukaemia virus: Unravelling the zoonotic transmission - a one health perspective , The Evidence: Vol. 2 No. 1 (2024): JAN - MAR
- Pawan Kumar, Asmitha Bhateja, Ankur Gupta, Role of artificial intelligence and machine learning in cardiovascular disease diagnosis and management: a bibliometric analysis , The Evidence: Vol. 1 No. 1 (2023): OCT - DEC
- Aroop Mohanty, Parul Singh, Ankita Kabi, Amogh Verma, Ranjit Sah, Role of micro-organism in cardiovascular diseases: a comprehensive review , The Evidence: Vol. 1 No. 1 (2023): OCT - DEC
